SCOPUS 정보 검색 플랫폼

Journal of Clinical Oncology

Volumn 20, Issue 9, 2002, Pages 2220-2222

Shedding old paradigms: Developing viruses to treat cancer

(2) Bergsland, Emily K a Venook, Alan P a

a UNIVERSITY OF CALIFORNIA (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; NEUTRALIZING ANTIBODY; PROTEIN P53; PV 701;

ADENOVIRUS; CANCER THERAPY; EDITORIAL; GENETIC ENGINEERING; HUMAN; INFECTION RISK; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; REOVIRUS; SOLID TUMOR; VESICULAR STOMATITIS VIRUS; VIRUS RECOMBINANT; VIRUS REPLICATION;

EID: 0036570108 PISSN: 0732183X EISSN: None Source Type: Journal
DOI: 10.1200/JCO.2002.20.9.2220 Document Type: Editorial

Times cited : (10)

References (13)

1
- 0030968315
- New phase I trial methodology
- (1997) Semin Oncol , vol.24 , pp. 253-261
- Mani, S.¹ Ratain, M.²

2
- 0036137897
- Impact of body-size measures on Irinotecan clearance: Alternative dosing recommendations
- (2002) J Clin Oncol , vol.20 , pp. 81-87
- Mathijssen, R.¹ Verweij, J.² De Jonge, M.³

3
- 0036569510
- Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
- (2002) J Clin Oncol , vol.20 , pp. 2251-2266
- Pecora, A.L.¹ Rizvi, N.² Cohen, G.I.³

4
- 0030616276
- Conditionally replicative adenoviruses for cancer therapy
- (1997) Adv Drug Deliv Rev , vol.27 , pp. 67-81
- Rancourt, C.¹ Curiel, D.²

5
- 0034927057
- Replication-selective virotherapy for cancer: Biological principles, risk management and future directions
- (2001) Nat Med , vol.7 , pp. 781-787
- Kirn, D.¹ Martuza, R.² Zwiebel, J.³

6
- 0031907053
- Therapeutic replication-competent herpes virus
- letter
- (1998) Nat Med , vol.4 , pp. 133
- Rampling, R.¹ Cruickshank, G.² Maclean, A.³

7
- 0035134629
- Clinical research results with d11520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: What have we learned?
- (2001) Gene Ther , vol.8 , pp. 89-98
- Kirn, D.¹

8
- 0034489718
- Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: Dependence on sequencing but not p53 functional status or route of administration
- (2000) Clin Cancer Res , vol.6 , pp. 4908-4914
- Heise, C.¹ Lemmon, M.² Kirn, D.³

9
- 0033693231
- Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an EIB-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: A phase II trial
- (2000) Cancer Res , vol.60 , pp. 6359-6366
- Nemunaitis, J.¹ Ganly, I.² Khuri, F.³

10
- 0033926002
- Replicative adenoviruses for cancer therapy
- (2000) Nat Biotechnol , vol.18 , pp. 723-727
- Alemany, R.¹ Balague, C.² Curiel, D.³

11
- 0035138689
- A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency
- (2001) Clin Cancer Res , vol.7 , pp. 120-126
- Suzuki, K.¹ Fueyo, J.² Krasnykh, V.³

12
- 0033895515
- The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing Herpes Simplex virus-tk: Assessment of antitumor efficacy and toxicity
- (2000) Canc Research , vol.60 , pp. 4167-4174
- Wildner, O.¹ Morris, J.²

13
- 0034980245
- Interleukin 12 secretion enhances antitumor efficacy of oncolytic Herpes Simplex viral therapy for colorectal cancer
- (2001) Ann Surg , vol.233 , pp. 819-826
- Bennett, J.¹ Malhotra, S.² Wong, R.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.